Fidelity Investments’s ProShares Ultra Health Care RXL Stock Holding History

Fidelity Investments’s Portfolio RXL Stock Details RXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2	Closed	-$83	–	5620
2023 Q3	$83	Buy	+2	New	+$88	﹤0.01%	4876
2022 Q3	–	Sell	-2	Closed	–	–	5326
2022 Q2	$0	Hold	2	–	–	﹤0.01%	5412
2022 Q1	$0	Buy	+2	New	+$96	﹤0.01%	5410
2021 Q4	–	Sell	-2	Closed	–	–	4853
2021 Q3	$0	Hold	2	–	–	﹤0.01%	4932
2021 Q2	$0	Buy	+2	New	+$87	﹤0.01%	4783
2021 Q1	–	Sell	-4	Closed	–	–	4466
2020 Q4	$0	Buy	+4	New	+$140	﹤0.01%	4233
2020 Q2	–	Sell	-4	Closed	–	–	4095
2020 Q1	$0	Buy	+4	New	+$115	﹤0.01%	4182

Other funds holding RXL

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

PFA

Plotkin Financial Advisors Chevy Chase, Maryland $199M AUM 19.26% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

CIAS

Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return

ORG Partners Roanoke, Indiana $568M AUM 24.16% 1-Year Est. Return

Fidelity Investments's RXL Position: Q4 2023 in Review

Fidelity Investments sold out of ProShares Ultra Health Care (RXL) in Q4 2023, closing a stake of 2 shares — an estimated $83 sold.

Fidelity Investments first reported a position in RXL in Q1 2020 and held it in 7 quarters. The position peaked at $83 in Q3 2023. 20 funds tracked by Wall St. Rank hold RXL as of Q4 2023.

Fidelity Investments reported no remaining ProShares Ultra Health Care position as of Q4 2023 after selling out during the quarter.
Fidelity Investments sold 2 ProShares Ultra Health Care shares in Q4 2023, an estimated $83.
Fidelity Investments first reported a position in ProShares Ultra Health Care in Q1 2020 and held it in 7 quarters.
Fidelity Investments's ProShares Ultra Health Care position peaked at $83 in Q3 2023.
20 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q4 2023.

Based on Fidelity Investments's 13F filing for Q4 2023, filed 13 Feb 2024.